[PDE5 inhibitors in the treatment of pulmonary hypertension]

Pharm Unserer Zeit. 2010 Sep;39(5):391-6. doi: 10.1002/pauz.201000385.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Clinical Trials as Topic
  • Hypertension, Pulmonary / drug therapy*
  • Hypertension, Pulmonary / physiopathology
  • Phosphodiesterase 5 Inhibitors / adverse effects
  • Phosphodiesterase 5 Inhibitors / chemistry
  • Phosphodiesterase 5 Inhibitors / pharmacology
  • Phosphodiesterase 5 Inhibitors / therapeutic use*

Substances

  • Phosphodiesterase 5 Inhibitors